McGuireWoods recently held its 16th annual Healthcare Finance & Growth Conference, during which speakers and industry leaders examined various subtopics in the healthcare space.
During the conference, Jeremy Johnson, Senior Managing Director, Head of Investment Banking at Bourne Partners, and Jeff Edwards, a partner at QHP Capital, participated in an afternoon panel discussion of current…
On this episode of The Banker’s Corner, McGuireWoods’ Geoff Cockrell talks to Craig Sager, director at Provident Healthcare Partners, about investing in primary care.
Craig, who leads the company’s sell-side M&A in primary care and behavioral health, shares his insights on investors working with fee-for-service healthcare groups. Some investors may find…
QHP Capital has announced it has acquired Applied StemCell.
Applied StemCell, founded in 2008 and based in Milpitas, Calif., develops gene editing and stem cell technology platforms designed to help advance broader cell therapy manufacturing.
QHP, based in Raleigh, N.C., is a private equity firm that pursues investments in lower middle market healthcare…
Bonaccord Capital Partners has made a passive minority investment in Revelstoke Capital Partners, according to a news release.
Revelstoke, based in Denver, focuses on investing in the healthcare and related business services sectors. Founded in 2013, the firm typically invests between $10 million and $250 million.
Bonaccord, based in New York, is…
In response to a growing number of cyberattacks in the healthcare and life sciences industries, on Sept. 27, 2023, the U.S. Food and Drug Administration (FDA) released updated guidance regarding cybersecurity safety requirements for medical devices. This guidance outlines the FDA’s recommendations on improving the cybersecurity safety and effectiveness of medical devices in the premarket…
On this episode of The Capital Corner, McGuireWoods’ Geoff Cockrell sits down with Hector Torres and Rich Blann, managing directors on DC Advisory‘s global healthcare team. They discuss market trends and current areas of interest from both investors’ and sellers’ perspectives.
Hector and Rich share the challenges they’ve seen in the market this…
The interview below is part of a McGuireWoods series featuring interviews with C-suite leadership of private equity-backed portfolio companies. To recommend a leader for a future interview, email Holly Buckley at hbuckley@mcguirewoods.com or Tim Fry at tfry@mcguirewoods.com.
Q: Can you tell us about Ambulatory Management Solutions (AMS)?
Scott Mayer (SM): AMS is an outpatient anesthesia…
Lovell Minnick Partners (LMP) has announced it has completed a majority investment in S&S Health.
S&S, founded in 1994 and based in Mason, Ohio, is a healthcare administration company providing solutions for health plans for small and mid-sized businesses.
LMP, based in Rednor, Pa., is private equity firm which seeks to invest in…
On Sept. 21, 2023, the Federal Trade Commission (FTC) brought a lawsuit in the U.S. District Court for the Southern District of Texas against US Anesthesia Partners (USAP), a large healthcare provider platform, and private equity firm Welsh, Carson, Anderson and Stowe (WC), which has been a principal investor in USAP for many years.
The…
Gurnet Point Capital and Novo Holdings have completed their acquisition of Paratek Pharmaceuticals in a deal valued at $462 million, according to a news release.
Paratek, founded in 1996 and based in Boston, is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for life-threatening diseases and other public health…
